Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jason L Schwartz

Showing results (41-50 of 60) with videos related to

Pageof 6
Sort By:
The Journal of Law, Medicine & Ethics : a Journal of the American Society of Law, Medicine & Ethics|April 8, 2025
FDA Advisory Committee Review of Supplemental Indications and Reasons for Non-Approval, 2008-2022Audrey D Zhang, Nikhil Chaudhry, Reshma Ramachandran, et al.
Health Affairs Scholar|July 15, 2026
Characterizing public participation in Prescription Drug User Fee Act reauthorization, 2010-2021Therese J Ziaks, Asuka Koda, Reshma Ramachandran, et al.
JAMA Internal Medicine|November 10, 2020
Speed, Evidence, and Safety Characteristics of Vaccine Approvals by the US Food and Drug AdministrationJeremy Puthumana, Alexander C Egilman, Audrey D Zhang, et al.
Journal of General Internal Medicine|March 4, 2021
Demographic Characteristics of Participants in Trials Essential to US Food and Drug Administration Vaccine Approvals, 2010-2020Audrey D Zhang, Jeremy Puthumana, Alexander C Egilman, et al.
Nature Immunology|May 22, 2012
Immune to addiction: the ethical dimensions of vaccines against substance abuseMichael J Young, Dominic A Sisti, Hila Rimon-Greenspan, et al.
JAMA|October 2, 2023
Kindergarten Vaccination Status in California After Changes to Medical Exemption PolicyPaul L Delamater, Alison M Buttenheim, Daniel A Salmon, et al.
Journal of General Internal Medicine|June 16, 2021
Characteristics of Preapproval and Postapproval Studies of Vaccines Granted Accelerated Approval by the US Food and Drug AdministrationAlexander Egilman, Joshua D Wallach, Jeremy Puthumana, et al.
Journal of Behavioral Medicine|February 23, 2022
Understanding the Factors Influencing Health Care Provider Recommendations about Adolescent Vaccines: A Proposed FrameworkMallory K Ellingson, Robert A Bednarczyk, Sean T O'Leary, et al.
JAMA Network Open|September 29, 2020
Evaluation of Cancer Care After Medicaid Expansion Under the Affordable Care ActMichelle C Salazar, Maureen E Canavan, Samantha L Walters, et al.
JCO Oncology Practice|June 10, 2025
Representation of Women, Older Adults, and Racial and Ethnic Minoritized Patients in Pivotal Trials for US Food and Drug Administration Novel Oncology Therapeutic Approvals, 2012-2021: Bright Spot Trials and Trends Over TimeJennifer E Miller, William Pelletiers, Cary P Gross, et al.
Pageof 6

Showing results (41-50 of 60) with videos related to

Sort By:
Pageof 6
The Journal of Law, Medicine & Ethics : a Journal of the American Society of Law, Medicine & Ethics|April 8, 2025
FDA Advisory Committee Review of Supplemental Indications and Reasons for Non-Approval, 2008-2022Audrey D Zhang, Nikhil Chaudhry, Reshma Ramachandran, et al.
Health Affairs Scholar|July 15, 2026
Characterizing public participation in Prescription Drug User Fee Act reauthorization, 2010-2021Therese J Ziaks, Asuka Koda, Reshma Ramachandran, et al.
JAMA Internal Medicine|November 10, 2020
Speed, Evidence, and Safety Characteristics of Vaccine Approvals by the US Food and Drug AdministrationJeremy Puthumana, Alexander C Egilman, Audrey D Zhang, et al.
Journal of General Internal Medicine|March 4, 2021
Demographic Characteristics of Participants in Trials Essential to US Food and Drug Administration Vaccine Approvals, 2010-2020Audrey D Zhang, Jeremy Puthumana, Alexander C Egilman, et al.
Nature Immunology|May 22, 2012
Immune to addiction: the ethical dimensions of vaccines against substance abuseMichael J Young, Dominic A Sisti, Hila Rimon-Greenspan, et al.
JAMA|October 2, 2023
Kindergarten Vaccination Status in California After Changes to Medical Exemption PolicyPaul L Delamater, Alison M Buttenheim, Daniel A Salmon, et al.
Journal of General Internal Medicine|June 16, 2021
Characteristics of Preapproval and Postapproval Studies of Vaccines Granted Accelerated Approval by the US Food and Drug AdministrationAlexander Egilman, Joshua D Wallach, Jeremy Puthumana, et al.
Journal of Behavioral Medicine|February 23, 2022
Understanding the Factors Influencing Health Care Provider Recommendations about Adolescent Vaccines: A Proposed FrameworkMallory K Ellingson, Robert A Bednarczyk, Sean T O'Leary, et al.
JAMA Network Open|September 29, 2020
Evaluation of Cancer Care After Medicaid Expansion Under the Affordable Care ActMichelle C Salazar, Maureen E Canavan, Samantha L Walters, et al.
JCO Oncology Practice|June 10, 2025
Representation of Women, Older Adults, and Racial and Ethnic Minoritized Patients in Pivotal Trials for US Food and Drug Administration Novel Oncology Therapeutic Approvals, 2012-2021: Bright Spot Trials and Trends Over TimeJennifer E Miller, William Pelletiers, Cary P Gross, et al.
Pageof 6